Contents
Our learning module on reducing the risks of benzodiazepines is derived largely from summaries of product characteristics supplemented by advice from the MHRA and other publicly available information.
The module is not designed to help you decide when to use a benzodiazepine. You should consult authoritative treatment guidelines for selecting the best treatment, taking into account clinical circumstances and the individual’s views.
We will review and update this learning module from time to time. Please complete the questionnaire at the end of the module to tell us what you think of it and to pass on any comments you would like us to consider.
1. Introduction
1.1 Class members
3. Principal risks and risk-reduction measures
3.1 Sedation and other adverse CNS effects
3.2 Respiratory adverse effects
3.3 Cadiovascular adverse effects
3.7 Overdose
3.8 Important drug interactions
4. Precautions and risks associated with special uses of benzodiazepines
4.1 Pregnancy and breastfeeding
4.2 Elderly
4.3 Benzodiazepines for the management of alcohol withdrawal
5. Key points
7. Appendix: Benzodiazepine prescribing trends
8.1 Feedback on self-assessment questions
9. Glossary
Page 1 of 24
